Hyperbaric Oxygen Therapy for Autism: Evidence Review and Recommendations

Hyperbaric oxygen therapy (HBOT) involves breathing 100% oxygen at pressures >1 atm. Despite theoretical rationale (reducing neuroinflammation, oxidative stress), current evidence does not support its use for autism spectrum disorder (ASD).

Evidence Summary

  • Systematic reviews (Cochrane, others): No high-quality RCTs show clinically meaningful improvement in core ASD symptoms (social communication, restricted behaviors).
  • Small, uncontrolled studies: Report transient improvements in some domains but suffer from placebo effects, lack of blinding, small samples.
  • AAP and CDC guidelines: Recommend evidence-based behavioral, educational, and developmental interventions; caution against unproven biomedical treatments.

Risks and Costs

  • Barotrauma (ears, sinuses, lungs).
  • Oxygen toxicity (seizures, retinopathy).
  • Fire hazard in oxygen-enriched chambers.
  • Cost: $100–$300/session; typically 40+ sessions recommended.
  • Time burden on families.

Clinical Position

HBOT for ASD remains experimental. Insurance generally doesn't cover it. Families should prioritize therapies with robust evidence (ABA, speech/OT, parent training) and discuss any complementary approach with their child's developmental pediatrician.

Resources

Autism - Related Articles